Home     Archives     Search     Authors     About Us     Subscribe     Contact Us  

Search For:
Search In:

The i2P magazine is distributed by email on a monthly basis. Subscription is free and you can unsubscribe at any time.
Subscribe Here
Unsubscribe Here

If you have any concerns for your privacy, please read our Privacy Policy

- Issue 81: April 2009
- Issue 80: March 2009
- Issue 79: February 2009
- Issue 78: December 2008
- Issue 77: November 2008
- Issue 76: October 2008
- Issue 75: September 2008
- Issue 74: August 2008
- Issue 73: July 2008
- Issue 72: June 2008

More Archives
We are in the process of moving all of our articles to the new site.

In the meantime you can find them on the old i2P site.

DVA & DAA - A Valuable Initiative

Stephen Carbonara
From an Independent Professional Pharmacist Perspective

Issue 79: February 2009
Page: 1 of 1 Author's Profile | Send to a Friend | Printer Version

The Department of Veteran Affairs (DVA) Dose Administration Aid (DAA) program is a new and, in my opinion, a valuable service.
For those who are unaware, basically the DVA funds the cost of Webster packs for veterans in the community to the tune of $10 per week, plus $100 per six-month review conducted by the pharmacist.
There are however a few logistical hurdles to jump through before each Veteran can be placed on the program.

The service is still mainly a GP-initiated service where they usually refer for a HMR then apply for a DVA authority prescription for the DAA service, which is to be dispensed for a $10 reimbursement each week for six months.
Towards the end of the six months; the pharmacist then completes a pro-forma review which recommends (or not) the service be continued for another six months.
The GP then re-applies for another six month DAA script.

This is a good service that is extremely worthwhile for all involved. It is definitely a step in the right direction.

However, one wonders a couple of things: Why can’t this service be available to all Australians?
Maybe this will be considered sometime in the future; and also: Why is it that the GP must initiate the service?
Surely pharmacists could similarly initiate the service using the same eligibility criteria, without having to increase the GP’s logistical workload?!

Maybe things will change in the future. In the meantime, I encourage everyone to actively get involved with this program.
This is the type of professional service funding that pharmacists need to promote.

Stephen Carbonara.

Back to Top | Back to Home
Copyright © Computachem Services, All Rights Reserved. Published by Computachem Services, PO Box 297 Alstonville 2477 NSW Australia